In silico analysis of functional non-synonymous and intronic variants found in a polycystic ovarian syndrome (PCOS) candidate gene: DENND1A by Moorthy, Janani Dakshina & Usha, Balasundaram
 
 
Indian Journal of Biochemistry & Biophysics 






In silico analysis of functional non-synonymous and intronic variants found in a 
polycystic ovarian syndrome (PCOS) candidate gene: DENND1A 
Dakshina Moorthy Janani & Balasundaram Usha*
 
Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, 
Kattankulathur-603 203, Tamil Nadu, India 
Received 04 March 2020; revised 31 July 2020 
The major thrust of our study confers to the identification of non-synonymous and intronic variants of the DENND1A 
gene via in silico methods and determination of its effect on the structural integrity of the protein. The outcome identifies 
potential disease -causing SNPs. The pathogenic variants of DENND1A were deduced via in silico analysis using various 
tools that include SIFT, PolyPhen-2, PROVEAN, SNP & GO, and PANTHER. The intronic variants were analysed using 
RegulomeDB. The 3D protein structure was obtained using the SWISS PDB modeler and validated by Ramachandran plots 
and QMEAN server. The effect on the stability of the protein structure caused by the SNPs was evaluated on the PYMOL 
and SWISS model platform. The functional changes caused by the SNPs were analysed in silico with I Mutant and Mutation 
Taster. The post-translational modifications were also predicted. STRING database was used for screening the protein 
interaction network. The SNPs rs2479106 and rs10986105 on the splice sites were found to be pathogenic for PCOS. The 
amino acid changes V179G and P331L were found to be disease-causing but the disease association with PCOS is yet to be 
validated.  
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A major purpose of human genetics is to comprehend 
the role of major genetic variants pathogenic to 
common diseases. This involves characterizing the 
gene variation found in human populations, arranging 
the extensive list of single-nucleotide polymorphisms 
[SNPs] of candidate genes together, and carrying  
out association studies for particular diseases.  
Before proceeding to any variant analysis in a 
population it is essential to characterize the variants 
using in silico tools. 
The tools provide information of the SNPs that 
alter the amino acid sequence of a gene product [non-
synonymous SNPs] and to discover the relationship 
between genetic and phenotypic variation; it is 
fundamental to determine the structural impact of the 
respective non-synonymous mutations on protein 
structure. Non – synonymous SNPs [nsSNPs] are 
sequence variants present as point mutations that lead 
to an alteration in the sequence of the encoded 
protein
1
. Usually, these variants are neutral, with little 
or no evident consequence on protein function, but 
some nsSNPs are known to be deleterious i.e. they are 
associated with either Mendelian or complex genetic 
diseases. Most of the SNPs that affect biological 
function occur outside the coding regions of genes 
namely the regulatory region and very few occur 
within the protein – coding sequence. Roughly there 
are around 13000 exonic SNPs per person, of which 
around 58% are non-synonymous
2
. These SNP effects 
upon gene-environment interaction develop various 
complex disorders in humans who are predisposed.  
The Poly Cystic Ovarian Syndrome (PCOS) is one 
such complex disorder with a gynecological 
endocrinopathy and affects 5-12% of women in their 
reproductive age and is associated with various metabolic 
and reproductive complications
3
. This syndrome is 
characterized by increased androgen secretion, 
anovulation, and polycystic ovary morphology. The 
long-term health risks may include infertility
4
, 
endometrial cancer and cardiovascular disorders. It is 
likely to be polygenic or oligogenic in origin
5,6
.  
GWAS (Genome-Wide Association Studies) 
studies for PCOS by Chen et al. and its replication 
studies in European cohorts have reported the 
DENND1A [differentially expressed in normal and 
neoplastic cells containing domain 1A] gene as a 
potential candidate marker
7,8









that overexpression of DENND1A can increase the 
possibility of a woman’s susceptibility to PCOS. 
More precisely, it is found that polymorphisms in the 
DENND1A.variant 2 [DENND1A.V2] lead to an 
increased expression of PCOS ovarian theca cells and 




Also, recently, DENND1A has been under the 
spotlight for finding the association between its 
mutants and disorders. DENND1A, a member of the 
connecdenn family, and it is found to show its major 
functions as guanine nucleotide exchange factor 
[GEFs] for the early endosomal small GTPase RAB35 
and also binds to the clathrin adaptor protein-2. This 
gene which consists of the clathrin domain and is 




DENND1A is found on the chromosomal region 
9q33.2 and consists of 22 exons that extend over 500000 
bases and encodes the protein DENN domain-containing 
1A [DENND1A], which contains an N-terminal DENN 
[differentially expressed in normal and neoplastic cells] 
domain, a common and evolutionarily ancient protein 
module. The primary structure of DENND1A protein is 
predicted to have DENN domains, a clathrin-binding 
motif, a proline-rich domain, and an adapter protein 
binding site at its C – terminal end (Fig. 1)
11,12
. 
Connecdenn1 is thought to be expressed primarily in 
brain and testis, although it can be detected in multiple 
additional tissues and cell lines
13
. A minimum of two 




We have tried to exclusively predict the effect of 
DENND1A variants on the functionality of the 
DENND1A protein and also deduce its role in PCOS 
pathophysiology via in silico analyses. Hence, the 
variants identified may give insight into the 
pathophysiology of PCOS thus helping the clinician 
identify a diagnosis module or treatment method after 
evaluating the risk ratio of the SNP in the population.  
 
Materials and Methods 
SNPs datasets 
The Online Mendelian Inheritance in Man [OMIM] 
and Entrez Gene on National Centre for Biological 
Information [NCBI] websites were used to retrieve 
the specifics for the DENND1A gene. The SNP 
information such as rs ID, functional class, variation 
class, clinical significance, and its allele frequency 
was obtained from the database of NCBI for SNPs 
[dbSNP] found at [https://www.ncbi.nlm.nih.gov/ 
snp]. Entrez Gene [http://grch37.ensembl.org/index. 
html] gave the gene’s details on chromosome location 
and coordinates in base pairs, consequence type, and 
amino acid coordinates. The list of rs IDs for further 
downstream analysis was obtained from dbSNP and 
also NCBI’s Variation Viewer [https://www.ncbi.nlm. 
nih.gov/variation/view/] since this table gives varied 
options for classification. The SNP list thus retrieved 
was combined and duplicates were removed for being 
used as input for the various in silico tools
15
. 
The SNPs identified by GWAS for PCOS were 
retrieved from PCOS knowledgebase [PCOSKB-
http://pcoskb.bicnirrh.res.in/] and the chromosome 
coordinates were given as input to RegulomeDB and 
Mutation Taster. 
The particulars on the DENND1A protein were 
obtained from UniProt Knowledgebase accessed from 
[http://www.uniprot.org/]. The mRNA accession 
number [NM_024820], the genomic DNA accession 
number [NC_000009.12 ] and the protein accession 
number [Q8TEH3] of the canonical structure which 
was used here for the native 3D structure and the 
FASTA sequence for mutation modelling was 




Fig. 1 — A diagrammatic representation of DENND1A gene in the chromosome 9_NC_000009.12 extracted from www.ncbi.nih.gov. 
Gene ID: 57706 




Functional analysis prediction of non-synonymous SNPs  
The tools SIFT, PolyPhen-2, PROVEAN, SNP & 
GO and PANTHER were used for characterizing the 
damaging effects of SNP. SIFT [http://sift.jcvi.org/] 
was used to identify the tolerance of an amino acid 
substitution on the protein’s function. SIFT predicts 
the deleterious effect of an nsSNP by using 
algorithms that align closely related sequences using 
PSI-BLAST and predict the damage using the degree 
of conservation of sequences. PolyPhen-2 [http:// 
genetics.bwh.harward.edu/pp2] abbreviated as 
Polymorphism Phenotyping version 2. PolyPhen helps 
to understand the probable impact of amino acid 
substitution on the structural and functional properties of 
the protein. It first characterizes using sequence-based 
methods followed by mapping the polymorphisms 
against the structure for generating scores. PROVEAN 
[http://provean.jcvi.org] tool enables predicting if an 
amino acid substitution has an effect on protein’s 
biological function and further filtering sequence 
variants to find out non-synonymous variants. 
PROVEAN was used to gather pair-wise sequence 
alignment scores to generate pre-computed predictions. 
SNP & GO is an accurate method that takes in to 
account the protein sequence and predicts whether  
the polymorphisms are disease-related variations or  
not by exploiting the functional annotation of  
the corresponding protein [http://snps.biofold.org/snps-
and-go/]. PANTHER [www.pantherdb.org/tools/csnp 
ScoreForm.jsp] was used to predict the damaging 
effect of nsSNPs by calculating the substitution position-
specific evolutionary conservation [sub-PSEC] score 
and thus to predict the amino acid substitution that will 





Prediction of DENND1A protein structure  
Protein BLAST
17
 was used to find the proteins that 
are similar to DENND1A. Identification of highly-
homologous sequences was done using a BLASTP 
search against every macromolecular structure deposited 
in protein data bank [http://www.rcsb.org/pdb/home]. 
SWISS-MODEL online protein modeling software 
was used to predict the structure of DENND1A 
protein since the 3D structure of DENND1A protein is 
not available in protein data bank
18
. We used SWISS-
MODEL [http://swissmodel.expasy.org/] to generate a 
3D structural model for DENND1A protein. SWISS-
MODEL is software that  uses homology modelling 
based structure prediction for automated protein 
structure modeling. Assigning the fold junctions, 
aligning the target according to the template 
sequences, building a model based on the alignment, 
and then validating the structure are the four stages 




Validation and evaluation of the predicted protein structure  
Stereochemical characterization of DENND1A protein 
was performed using RAMPAGE. Ramachandran plot  
is a scattered two-dimensional plot of Φ and Ψ  
pairs comparing them to a predicted distribution. 
[http://modred.bioc.cam.ac.uk/~rapper/rampage.php] 
RAMPAGE Ramachandran plot uses database statistics 
for validation of modeled protein structure
20
. 
Evaluation of protein structure was carried out 
using the QMEAN server. The QMEAN server 
[http://swissmodel.expasy.org/qmean] provides access 
to both composite scoring function QMEAN and 
clustering method QMEAN clust. QMEAN score is a 
calculation of 6 various terms [1] C_ interaction 
energy [2] all-atom pairwise energy [3] solvation 
energy [4] torsional angle energy [5] solvent 
accessibility agreement and [6] total QMEAN-score. 
 
The post-translational modification sites on DENND1A 
protein 
Glycation sites of ε amino groups of lysine residues 
were predicted using a NetGlycate 1.0 server [http:// 
www.cbs.dtu.dk/services/NetGlycate/]. In NetGlycate 
a score of >0.5 was considered to be a site for 
glycation. Phosphorylation sites were predicted using  
a NetPhos2.0 sever [http://www.cbs.dtu.dk/services/ 
NetPhos/]. In NetPhos2.0, serine, threonine, and 
tyrosine residues with a score of >0.5 were considered 
to be phosphorylated
21,22
. Ubiquitylation sites were 
predicted using UbPred [www.ubpred.org]. In 
Ubpred, lysine residues with a score of ≥ 0.62 were 
considered ubiquitylated. Sumoylation is important 
for the protein to attain its correct conformation and 
thus these sites were predicted using SUMOplot 
[http://www.abgent.com/sumoplot]. For SUMOplot 
high probability motifs having a score of 0.5 were 
considered sumoylated. 
 
DENND1A interacting protein partners  
Protein-protein interaction networks are eminent to 
uncover and annotate all functional interfaces among 
cell proteins. To find out the interaction of DENND1A 
protein with other cell proteins, the online database 
resource ―Search Tool for the Retrieval of Interacting 
proteins‖ [STRING; http://string-db.org/] was used. 
This imparted the knowledge relating to the unique 
relations and convenient access to both experimental 




and theoretical interaction evidence of - DENND1A. 
The input options for the STRING database include 





Predicting the effect of SNPs on protein stability 
I-Mutant 2.0 [http://folding.biofold.org/i-mutant/i-
mutant2.0.html], a neural network-based tool, predicts 
the variation in the stability of the protein upon 
mutation. This tool automatically predicts protein 
stability changes upon single-site mutations. 
Prediction can be done using a protein structure or 
sequence from databases. The FASTA sequence of 
the DENND1A protein with the accession number 
Q8TEH3 was retrieved from UNIPROT to predict the 
mutational effect on protein stability. Output 
illustrates mutations with respect to the change in 
stability and Gibbs-free energy change [G]. The 
energy change due to the incorporation of the 
mutation was calculated using the SWISS PDB 
VIEWER software. The mutations were incorporated 
in the predicted structure using the PyMol software 
and the mutated proteins were used for predicting the 




The dbSNP database contains both legitimated and 
not legitimated polymorphisms. Despite these 
shortcomings, dbSNP was used because it is the most 
elaborate SNP database. DENND1A gene contains 
1,16,762 SNPs compiled from NCBI and the dbSNP 
database. This list was then manually curated to 
validate the mutations. When these SNPs were 
filtered to have their multiple allele frequencies in the 
range of 0.05 to 0.49, only 1984 SNPs were 
displayed. This list was furthered filtered using a 
heterozygosity score of 40 – 50 to obtain only 577 
SNPs to be validated using dbSNP – Q and those SNP 
which have been withdrawn were deleted. Thus a list 
of 215 SNPs remains, which was merged with the 
SNP list from the variation viewer platform to give a 
list of 890 SNPs to be used as input for further 
downstream analyses.  
 
Deleterious nsSNPs of DENND1A gene  
The above-curated list of 890 SNPs was fed as 
input for SIFT program that screens for intolerable 
SNP mutations (Table 1). SIFT reported 4 prominent 
SNPs out of which 3 reported being deleterious. We 
used PROVEAN and PANTHER to characterize  
the functional substitution effect through evolutionary 
relationship classification in DENND1A protein. 
PROVEAN is advantageous for proteins like DENND1A 
where only the primary structure is known and it  
has predicted only 2 SNPs as deleterious whereas 
PANTHER predicts 3 SNPs as majorly deleterious as 
they occur in a highly conserved region. PANTHER 
predicts the deleterious SNPs based on the PSEP 
[Position Specific Evolutionary Preservation] score 
when the PSEP score is ≥ 200my [million years] and 
those with a score of < 200my is said to be benign. 
SNP & GO gave positive disease-causing damaging 
effects for 2 SNPs; V179G and P331L, respectively. 
All the results are briefed in (Table 1). These SNPs 
were used for further structural analysis.  
 
DENND1A SNPs identified by GWAS for PCOS 
The SNPs listed by GWAS and the RegulomeDB 
output is summarized in (Table 2). The intronic 
variants identified by GWAS were further scrutinized 
for their disease-causing ability using Mutation 
Taster. It was found that two of the reported SNPs 





Sift  Provean  Panther  Snp & Go  Polyphen2 
Score Prediction Score Prediction 
Preservation 
Time (My) 
Prediction Score Prediction Score Prediction 
rs78862236 V179G 0 Damaging 6.575 Damaging 842 Damaging 0.881 Damaging 1 Damaging 
rs112018705 T519M 0 Damaging 1.519 Neutral 361 Damaging --- --- 0.99 Damaging 
rs115363971 P331L 0 Damaging 8.444 Damaging 750 Damaging 0.925 Damaging --- --- 
rs116352541 P827S 0.09 Tolerant 0.406 Neutral ---- ----- --- --- --- --- 
 
Table 2 — REGULOMEdb score for intronic polymorphisms in DENND1A gene 
Chromosome Coordinates Coordinates rs ID Regulome Score 
chr9 126446777 126446778 rs10818854 4 
chr9 126525211 126525212 rs2479106 5 
chr9 126549954 126549955 rs10986105 5 




[rs2479106 & rs10986105] were found to alter a 
splicing region in the upstream and thus affects 
almost all protein features of DENND1A (Fig. 2).  
Interestingly, the analysis also predicted another SNP 
[rs112018705] in the protein-coding region which is 
highly damaging and decreases the protein stability.  
 
Modeling and validating structural stability of DENND1A 
protein 
The prediction of the structure of DENND1A is 
essential for understanding the structural variation 
possibly caused due to a mutation. SWISS-MODEL 
was used as a web-based platform to generate a 3D 
structure model for wild-type DENND1A. The input 
template required for modeling was obtained by 
running a BLASTP algorithm against the PDB 
database. A template of DENND1B -Chain A, GEF 
domain complex with Rab GTPase Rab35, showed 
69% identity with DENND1A and was chosen for 
homology modeling. Once the template sequence and 
the target sequence were aligned, the 3D model was 
constructed automatically using an auto-model class. 
The homologous model generated using a template 
[SMTL id 3tw8.2] covered a total of 376 residues 
starting from met1 to asn376 position out of 1009 amino 
acid residues of DENND1A protein (Fig. 3). This region 
is found to be similar in both the variants as the variant 2 
has the first 559 amino acids similar to the variant 1. The 
variant 2 lacks the proline-rich domain and has some 
alterations in the C-terminal domain.  
Ramachandran Plot was used to validate the protein 
model obtained from SWISS-MODEL workspace, 
according to which 378 residues were obtained in the 
final DENND1A model (Fig. 4). Out of all the amino 
acids, 360 [96.3%] were in the most favourable 
region, 11 [2.9%] in allowed regions, and 3 [0.8%] in 
disallowed regions. Hence, the stability of SWISS-
MODEL is acceptable. The QMEAN score consists of 
a linear combination of 6 terms. The pseudo energies 
of the contributing terms are the total Q mean score 
which is relatable with its z-score -1.86, which comes 
from under an estimated model reliability value 
between 0 and 1.  
 
Post-translation modification and ligand binding sites on 
DENND1A protein 
We used various in silico tools to study how 
nsSNPs influence post-translational modification of 
 
 
Fig. 2 — Mutation Taster results for SNPs rs 2479106 and rs 10986105 which were identified via GWAS 
 
 
Fig. 3 — A pictorial representation of DENND1A protein 
structure that was predicted partially from 1 to 376 using SWISS 
MODELER platform and validated using the Ramachandran plot. 
This representation was visualized using PyMol software 




DENND1A protein. NetGlycan predicted that 12 
residues undergo glycation. According to NEtPhos, 
70 threonine, 105 serine, and 10 tyrosine residues 
undergo phosphorylation. Protein sequence with a 
mutational position and amino acid variant associated 
with nsSNPs were submitted as input in UbPred, 17 
residue positions have a confidence level that is 
capable of variations (Table 3). Similarly, with 
SUMOplot we predicted that there are 8 different 




A 3D molecular structure becomes meaningful 
only when its context with other proteins is identified 
through its assembly, regulation, and signalling 
interactions. The STRING provides such a platform to 
understand in detail about the protein interaction, 
which is a report based on critical assessment of 
curated data from experiments and databases. The 
Figure 5 shows the first-line interacting proteins with 
DENND1A. Three of the major interacting proteins 
with DENDD1A as reported by STRING are (i) 
Rab35, an important protein responsible for 
membrane protein trafficking inside a cell; (ii) CLTB 
and CLCT, Clathrin light chains and heavy chains, 
respectively, which coat the pits in vesicles for 
endocytosis; (iii) GAK, essential for uncoating of 
Clathrin-coated pits. Surprisingly NEK6 and NEK7, 
which are responsible for regulating meiotic spindle 
formation, are also key interactors of DENND1A thus 
showing the indirect association of DENND1A in cell 
cycle regulation. Other important first line interacting 
proteins are CRB2, IFT27, and CENPJ.  
 
Effect of mutations on the stability of the protein 
DENND1A mutants were modeled against their 
wild-type using PyMOL (Fig. 6). A comparative and 
superimposed observation showed no difference 
between the mutants and the wild-type. They were 
hence extensively studied. The total energy after 
minimization and electrostatic constraint of native 
protein were 21245.529 kJ/mol and 12995.61 kJ/mol 
 
 
Fig. 4 — Ramachandran plot validation output graph from the 
SWISS MODELER predicted protein. The plot shows that the 
structure can be considered valid and that 96.3% of the predicted 
residues portion fall under favorable region 2.9% in the allowable 
regions and 0.8% in the disallowed region 
Table 3 — UbPred Scoring that predicts the possible 
ubiquitination in the DENND1A protein structure 
Residue Score Ubiquitination 
6 0.68 Yes Low confidence 
452 0.67 Yes Low confidence 
469 0.82 Yes Medium confidence 
479 0.71 Yes Medium confidence 
482 0.89 Yes High confidence 
553 0.92 Yes High confidence 
591 0.76 Yes Medium confidence 
600 0.69 Yes Medium confidence 
637 0.62 Yes Low confidence 
651 0.71 Yes Medium confidence 
659 0.87 Yes High confidence 
686 0.87 Yes High confidence 
723 0.76 Yes Medium confidence 
937 0.79 Yes Medium confidence 
980 0.88 Yes High confidence 
982 0.92 Yes High confidence 
1003 0.63 Yes Low confidence 
 
Table 4 — Sumoylation predicted by Sumoplot that gives a 
prediction on possible sumoylation that can occur in  
DENND1A protein variant 2 
Number Position Group Score 
1 K427 SYRNALKIEPEEPI 0.91 
2 K608 PRPHVVKRPKSNIA 0.82 
3 K540 FAKDHAKMGIKEVK 0.62 
4 K703 EDLRAPKDLREQP 0.61 
5 K791 ILNPSDKEEVPTPT 0.5 
6 K465 Q LQLFKQFIDGRL 0.5 
7 K233 LLETLHKLPIPDPG 0.41 
8 K811 PRPQGRKTPELGIV 0.34 




whereas, that of the Mut179 were 21138.232 kJ/mol 
and 12352.56 and Mut331 were 21275.221 kJ/mol 
and 12420.47. The energy of the mutant structures 
showed thermodynamically favourable changes in 
comparison with the wild-type. These genomic variants 
have the probability of further decreasing the stability 
of the DENND1A protein. 
Stability prediction [∆G] and reliability index [RI]  
upon mutation of the protein was reported by I – 
MUTANT (Table 5). Those SNPs which are reported to 
be damaging or deleterious by SIFT, PolyPhen, 
PROVEAN, and PANTHER were given as input. There 
are higher chances that protein stability might decrease 
due to mutations at positions179, 519, 331, and 827. 
Thus, the stability will be more affected at position 331 
and 179 when compared to the rest of the residues. 
 
Discussion 
Trait variation among the world population is 
contributed by Single Nucleotide Polymorphisms 
 
 
Fig. 5 — A pictorial representation of the first line interacting proteins shows that DENND1A have major interactions with Rab35, CLTB, 
CLCT, GAK, NEK6 and NEK7, CRB2, IFT27 and CENPJ  
Table 5 — I-Mutant table that gives the change in the stability  
of protein with an introduction of polymorphism 
Position WT New Stability RI pH T 
179 D G Decrease 7 7.0 25 
519 G M Decrease 5 7.0 25 
331 V L Decrease 8 7.0 25 
827 Q S Decrease 5 7.0 25 
 
 
Fig. 6 — DENND1A protein structure predicted using SWISS 
MODELER and mutation incorporated structure using PyMol protein 
visualization software to understand the possibility of structural 
isolation due to the incorporation of mutation. (A) Native structure 
with Proline at position 331; (B) Mutation of Leucine incorporated at 
position 331; (C) Native structure with Valine at position 179; and 
(D) Mutation of Glycine incorporated at position 179 




[SNPs]. SNP is a position at which two of the alleles 
occur at an appreciable frequency [0.1%] in the human 
population and are stable because of the low rate of 
recurrent mutation making them a probable biomarker
24
. 
Such inherited differences in the DNA sequence 
contribute majorly to the phenotypic variation thus 
affecting an individual’s anthropometric characteristics; 
response to the environment and possibility of a disease. 
Thus, SNPs may serve as genetic markers for screening 
disease-causing genes through family analysis for 
linkage studies, investigating the linkage disequilibrium 
among the isolated population, association analysis of 
patients and controls etc
25
.  
Polycystic Ovarian Syndrome [PCOS] is one such 
complex disorder where the disease manifests due to the 
altered response of the variants to the environment
26
. 
Though each interaction and response needs to be 
studied in detail to unravel the pathophysiology, initial 
in silico analysis of the candidate genes and its variants 
may give indications for translational analysis.  
For PCOS, six Genome-Wide Association Studies 
[GWAS] have been carried out until now and has listed 
out more than 20 candidate genes
9,10,27-31
. DENND1A 
SNPs were identified as potentially pathogenic by three 
of the GWAS and many literatures give the association 
of DENND1A with PCOS
32,33
. The in silico analysis of 
this gene carried out in this study, has revealed a few 
pathogenic mutations leading to alterations in the protein 
structure and consequently its function.  
Usually, the nsSNPs present on the shell of a 
protein is possibly tolerated but those identified by 
GWAS are positioned at functionally important sites 
like the splicing region and thus alter the protein 
structure, protein-protein interface and ultimately 
impair the protein’s stability
34
.  
Apart from the 3 DENND1A SNPs identified by 
GWAS studies for PCOS, our in silico analysis has 
identified 4 other SNPs. These SNPs are present in the 
coding region and are found to be highly pathogenic. 
But the disease associations of these variants are yet to 
be studied. The identified pathogenicity can be 
authenticated by the fact that almost all the disease-
causing mutations are present on the sites which are 




It is also known that the splicing mechanism of 
DENDD1A gives rise to two variants – DENND1A 
Variant 1 and DENND1A Variant 2. The longer of 
these transcripts, variant1, encodes 1009 amino-acid 
protein which consists of a C-terminal proline-rich 
domain. The variant 2 encodes a truncated 559 amino-
acid protein that contains the DENN domain and the 
clathrin-binding domain, but it does not contribute the 
proline-rich domain and it also contains a C-terminal 
33 amino-acid sequence which is not found in the 
larger connec denn 1 variant
39
. 
The DENND1A Variant 2 is more closely associated 
with PCOS by activating the signal transduction 
cascades and regulating it via gonadotropins. It also 
increases the expression of steroidogenic enzymes by 
regulating the intranuclear transport of signal transducers 
in conjunction with DENND1A Variant 1
40
. The 
DENND1A Variant 2 expressed on the ovarian theca 
cells is responsible for androgen biosynthesis and a 




Thus the DENN domains and Clathrin Binding 
motifs are conserved in both the variants and thus the 
SNPs found in these regions may play a role in 
causing PCOS. By using Caenorhabditis elegans as a 
model organism it was shown that the DENN domain 
which binds to Rab-35 is responsible for the recruitment 
of this protein to Clathrin-Coated Vesicles [CCVs] for 
subsequent transport to endosomes where it controls 
yolk receptor recycling
41
. Thus the [GWAS] SNPs 
which are found to be altering the protein function of 
the DENN Domain may play a major role in PCOS.  
Post Translational Modification [PTM] are important 
for protein localization, enzyme activity, degradation 
and interaction with other proteins to give signals. Some 
important PTMs which we have screened are for 
phosphorylation, glycosylation, ubiquitination, and 
sumoylation. The DENN domain has a sumolytion 
region while the proline-rich region has the most PTM 
sites. It has 4 sumolytion sites, 7 ubiquitination sites, 
18 serine phosphorylation sites, and 14 threonine sites. 
It was found that the rs2479106 (Table 2) lies on a 
conservatory motif – Hmbox1, which is a Transcription 
Factor Binding site.  
 
Conclusion 
Through this study, in silico analysis, we have listed 
the most potential variants of DENND1A  associated to 
Polycystic Ovarian Syndrome. The intronic variants 
previously reported in the Chinese, and European 
populations were found to affect the transcription 
process. Similarly, the predicted damaging nsSNPs 
reported in our study, affect the stability of the protein 
and thus alter the bio functionality of DENND1A. The 
instability of the DENND1A might affect the function 




of the protein and its downstream processes and thus 
contribute to the pathology of PCOS.  
The DENND1A seems to play a major role in 
androgen biosynthesis and malfunction or 
overexpression of a particular type of DENND1A variant 
[DENND1A Variant 2] leads to an increased steroid 
hormone biosynthesis. This information hints us on the 
fact that the SNPs on DENDD1A may lead to a 
hyperandrogenic phenotype of PCOS and thus may help 
in precise diagnosis and treatment. Thus to verify the 
identified nsSNP’s association with this disease state, 
population screening needs to be done for the respective 
ethnic population.  
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